IN-HOUSE MANUFACTURING SPECS SHOULD NOT BE CONFUSED WITH REGULATORY DEMANDS FOR ICH Q6A; COMMON TECHNICAL DOSSIER ADOPTED AS TOPIC FOR EXPLORATION
Executive Summary
In-house manufacturing process specs should not define regulatory requirements in the International Conference on Harmonization quality guideline, participants recommended at an Aug. 19-21 drug spec setting conference in Washington, D.C.